Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Anti‐pseudomonal Antibiotics for Long‐term Therapy in Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433165/all/Inhaled_anti‐pseudomonal_antibiotics_for_long‐term_therapy_in_cystic_fibrosis.
Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433165/all/Inhaled_anti‐pseudomonal_antibiotics_for_long‐term_therapy_in_cystic_fibrosis. Accessed March 12, 2026.
Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433165/all/Inhaled_anti‐pseudomonal_antibiotics_for_long‐term_therapy_in_cystic_fibrosis
Inhaled Anti‐pseudomonal Antibiotics for Long‐term Therapy in Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 March 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433165/all/Inhaled_anti‐pseudomonal_antibiotics_for_long‐term_therapy_in_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis
ID - 433165
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433165/all/Inhaled_anti‐pseudomonal_antibiotics_for_long‐term_therapy_in_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

